UNITED THERAPEUTICS Corp — Director's Dealing 2021

Jun 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2021-06-03

Reporting Person: MAHON PAUL A (EVP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-03	Common Stock	M	6000	$94.96	Acquired	42369	Direct
2021-06-03	Common Stock	D	6000	$175.24	Disposed	36369	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-03	Share Tracking Award	$94.96	M	6000	Disposed	2024-03-14	Common Stock (6000)	Direct

Footnotes

F1: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.